Advertisement

Reactions Weekly

, Volume 1723, Issue 1, pp 137–137 | Cite as

Erlotinib

Developement of drug resistance in lung adenocarcinoma: case report
Case report

Reference

  1. Zhu Y-C, et al. MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma. Journal of Thoracic Oncology 13: e202-e204, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.05.009 - China

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations